Comparative efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: a systematic review and meta-analysis

Hai Wang,Man Lb,Guizhong Li,Guanglin Huang,Jianwei Wang

Comparative efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: a systematic review and meta-analysis

2016

Hai Wang
Man Lb
Guizhong Li
Guanglin Huang
Jianwei Wang

Objective This study was performed to evaluate the comparative efficacy and safety of axitinib and sorafenib in the therapy of metastatic renal cell carcinoma.

Keywords:

Axitinib
Cancer research
Renal cell carcinoma
Oncology
Sorafenib
Pathology
Internal medicine
Medicine
Randomized controlled trial
Progression-free survival
Meta-analysis
Hazard ratio
Adverse effect

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations